|
"Comparison of IV ketamine with Standard Analgesia for treatment of vaso occlusive crisis in sickle cell disease."
|
Ongoing
|
ESKETAMINE HCL
|
3
|
2211021
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A randomized double-blind placebo-controlled parallel group study assessing the efficacy and safety of dupilumab in patients with Allergic Fungal Rhinosinusitis (AFRS)
|
Ongoing
|
Dupilumab
|
3
|
EFC16724
|
King Khalid University Hospital (Riyadh),King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A Phase 2 study of PHE885, B-cell maturation Antigen (BCMA)-directed CAR-T Cells in adult participants with relapsed and refractory multiple myeloma.
|
Ongoing
|
PHE885 (CAR-T Cell)
|
2
|
CPHE885B12201
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Stress Hydrocortisone in Pediatric Septic Shock (The SHIPSS trial)
|
Ongoing
|
Hydrocortisone
|
4
|
SCT22R/009
|
King Abdulaziz Medical City NG (Riyadh)
|
|
iOUTRUN: Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients
|
Ongoing
|
Benralizumab
|
4
|
D3250R0011
|
King Fahad Medical City (Riyadh) , King Faisal Specialist Hospital and Research Center (Jeddah),International Medical Center (Jeddah)
|
|
"Nintedanib in patients with bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation – a multicentre phase II trial"
|
Ongoing
|
NINTEDANIB
|
2
|
Amendment 3 F02
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
An open-label, controlled, multi-site, Phase 2 clinical trial to assess the ureagenesis capacity in newborns and infants up to the age of 12 months with neonatal and infantile onset of urea cycle disorders (UCD) using a 15N ammonium chloride tracer compared to newborns and infants without UCD
|
Rejected
|
15NH4Cl tracer assay
|
2
|
HLSC-UCD-01
|
King Abdulaziz Medical City NG (Riyadh)
|
|
A Phase 2 Open-label, Dose Escalation Study of HST5040 in Subjects with Propionic or Methylmalonic Acidemia Followed by a 6-Month, Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study and an Open-label, Long-term Extension Study
|
Terminated
|
ST5040 (2,2-dimethylbutanoic acid)
|
4
|
HST20-CL01
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
An observational disease and clinical outcomes registry of patients with acid lipase (LAL) deficiency
|
Ongoing
|
Kanuma
|
4
|
ALX-LALD-5
|
King Faisal Specialist Hospital and Research Center (Riyadh) , King Abdulaziz Medical City NG (Riyadh)
|
|
A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature
|
Ongoing
|
Sogroya , Norditropin
|
3
|
NN8640-4467
|
King Faisal Specialist Hospital and Research Center (Riyadh) , King Abdulaziz Medical City NG (Riyadh)
|
